XML 55 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2023
USD ($)
uS_Dollar_Per_Share
Dec. 31, 2022
USD ($)
uS_Dollar_Per_Share
Dec. 31, 2021
USD ($)
uS_Dollar_Per_Share
Dec. 31, 2020
USD ($)
uS_Dollar_Per_Share
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
Mr. Cordani:
Fiscal Year
Summary Compensation
Table Total
Compensation
Actually Paid
Ratio of Compensation Actually Paid to Summary Compensation Table Total
2023$21,047,255$8,153,2580.39
2022$20,965,504$57,388,9942.74
2021$19,872,266$15,448,9060.78
2020$19,929,493$15,872,5370.80
Other NEOs:
Fiscal Year
Summary Compensation
Table Total
Compensation
Actually Paid
Ratio of Compensation Actually Paid to Summary Compensation Table Total
2023$6,801,329$3,521,1330.52
2022$6,346,552$15,496,8622.44
2021$7,164,215$5,232,4980.73
2020$7,075,762$5,955,2950.84
Summary
Compensation
Table Total for
Mr. Cordani
($)
Compensation
Actually Paid
to Mr. Cordani
($)
Average
Summary
Compensation
Table Total
for NEOs
(other than
Mr. Cordani)
($)
Average
Compensation
Actually Paid
to NEOs
(other than
Mr. Cordani)
($)
Value of Initial Fixed
$100 Investment
Based On:
Net
Income(2)
(in millions)
($)
Company
-Selected
Measure:
Adjusted
Income from Operations,
per share (3)
($)
Fiscal
Year
Company
TSR
($)
Peer
Group
TSR(1)
($)
(b)(c)(d)(e)(f)(g)(h)(i)
2023$21,047,255$8,153,258$6,801,329$3,521,133154.34143.185,16425.09
2022$20,965,504$57,388,994$6,346,552$15,496,862167.71140.29
6,704(4)
23.36(4)
2021$19,872,266$15,448,906$7,164,215$5,232,498114.34143.09
5,370(4)
20.48(4)
2020$19,929,493$15,872,537$7,075,762$5,955,295101.83113.458,45818.45
      
Company Selected Measure Name Adjusted Income from Operations, per share      
Named Executive Officers, Footnote
The NEOs (other than Mr. Cordani) reflected in columns (d) and (e) of the Pay Versus Performance Table are represented by the following individuals for each fiscal year as shown below:
202320222021
2020
Brian C. EvankoBrian C. EvankoBrian C. Evanko
Eric P. Palmer
Noelle K. EderNoelle K. EderNicole S. JonesNicole S. Jones
Nicole S. JonesNicole S. JonesEric P. Palmer
Timothy Wentworth
Eric P. PalmerEric P. PalmerTimothy Wentworth
Matthew Manders
Matthew Manders
      
Peer Group Issuers, Footnote Peer Group reflects published data for the S&P 500 Health Care Index.      
PEO Total Compensation Amount $ 21,047,255 $ 20,965,504 $ 19,872,266 $ 19,929,493
PEO Actually Paid Compensation Amount $ 8,153,258 57,388,994 15,448,906 15,872,537
Adjustment To PEO Compensation, Footnote
To calculate the Compensation Actually Paid reflected in the Pay Versus Performance Table above, the following amounts were deducted from and added to the Summary Compensation Table total compensation for each fiscal year:
Mr. Cordani’s Summary Compensation Table Total to Compensation Actually Paid Reconciliation
Fiscal
Year
Salary
($)
Stock
Awards
($)
Bonus &
Non-Equity
Incentive
Comp.
($)
All Other
Comp.
($)
Change in
Pension
Value &
NQDC
Earnings
($)
Summary
Comp.
Table Total
($)
Stock Award
Deductions
from Summary
Comp.
Table Total(1)
($)
Stock Award
Additions to
Summary Comp. Table Total(2)
($)
Comp.
Actually Paid(3)
($)
2023$1,500,000$15,856,233$3,300,000$310,437$80,585$21,047,255$(15,856,233)$2,962,236$8,153,258
2022$1,500,000$15,544,307$3,600,000$321,197$0$20,965,504$(15,544,307)$51,967,797$57,388,994
2021$1,500,000$15,370,427$2,700,000$301,839$0$19,872,266$(15,370,427)$10,947,067$15,448,906
2020$1,500,000$14,560,254$3,500,000$179,341$189,898$19,929,493$(14,560,254)$10,503,298$15,872,537
Represents the grant date fair value of equity-based awards granted each year.
(2)Reflects the value of equity calculated in accordance with the SEC methodology for determining Compensation Actually Paid for each year shown. The equity component of Compensation Actually Paid for each fiscal year is further detailed in the tables below:

Mr. Cordani’s Compensation Actually Paid Equity Valuation for Each Fiscal Year
2023 Compensation Actually Paid Equity Valuation
Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2023
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2023
($)
Change in
Fair Value of
Awards that
Vested in 2023
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2023
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$3,106,749$(2,098,800)$(2,374,503)$0$(1,366,555)
Restricted Stock$3,252,626$(451,849)$(640,466)$0$2,160,310
Strategic Perf Shares$8,773,351$(5,212,929)$(1,391,941)$0$2,168,481
Total$15,132,725$(7,763,578)$(4,406,911)$0$2,962,236
2022 Compensation Actually Paid Equity Valuation

Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2022
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2022
($)
Change in
Fair Value of
Awards that
Vested in 2022
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2022
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$7,876,809$6,875,723$444,986$0$15,197,518
Restricted Stock$4,232,869$1,767,720$38,838$0$6,039,426
Strategic Perf Shares$17,751,119$12,979,546$188$0$30,730,853
Total$29,860,797$21,622,989$484,012$0$51,967,797

2021 Compensation Actually Paid Equity Valuation
Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2021
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2021
($)
Change in
Fair Value of
Awards that
Vested in 2021
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2021
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$4,385,246$382,720$(555,181)$0$4,212,785
Restricted
Stock		$3,893,606$392,213$26,005$0$4,311,824
Strategic Perf Shares$6,977,016$(4,619,317)$64,758$0$2,422,457
Total$15,255,868$(3,844,384)$(464,418)$0$10,947,067

 
2020 Compensation Actually Paid Equity Valuation
Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2020
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2020
($)
Change in
Fair Value of
Awards that
Vested in 2020
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2020
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$3,749,535$(241,674)$(1,637,861)$0$1,870,000
Restricted
Stock		$3,794,705$45,261$(114,871)$0$3,725,095
Strategic Perf Shares$7,929,201$(1,965,506)$(1,055,492)$0$4,908,203
Total$15,473,441$(2,161,919)$(2,808,224)$0$10,503,298
No pension-related adjustments associated with the Cigna Pension Plan were necessary in the calculation of Compensation Actually Paid as the plan is frozen and there were no prior service costs established in the last three years. 		     
Non-PEO NEO Average Total Compensation Amount $ 6,801,329 6,346,552 7,164,215 7,075,762
Non-PEO NEO Average Compensation Actually Paid Amount $ 3,521,133 15,496,862 5,232,498 5,955,295
Adjustment to Non-PEO NEO Compensation Footnote
To calculate the Compensation Actually Paid reflected in the Pay Versus Performance Table above, the following amounts were deducted from and added to the Summary Compensation Table total compensation for each fiscal year:
Average NEOs’ (other than Mr. Cordani) Summary Compensation Table Total to Compensation Actually Paid Reconciliation
Fiscal
Year
Salary
($)
Stock
Awards
($)
Bonus &
Non-Equity
Incentive
Comp.
($)
All Other
Comp.
($)
Change in
Pension
Value &
NQDC
Earnings
($)
Summary
Comp.
Table Total
($)
Stock Award
Deductions
from Summary
Comp.
Table Total(1)
($)
Stock Award
Additions to
Summary Comp. Table Total(2)
($)
Comp.
Actually Paid(3)
($)
2023$875,288$4,500,529$1,365,000$50,046$10,466$6,801,329$(4,500,529)$1,220,332$3,521,133
2022$827,549$4,236,986$1,230,625$51,392$0$6,346,552$(4,236,986)$13,387,296$15,496,862
2021$995,385$4,731,519$604,500$829,680$3,131$7,164,215$(4,731,519)$2,799,802$5,232,498
2020$1,001,923$4,503,476$1,470,625$55,835$43,903$7,075,762$(4,503,476)$3,383,009$5,955,295
(1)Represents the grant date fair value of equity-based awards granted each year.
(2)Reflects the value of equity calculated in accordance with the SEC methodology for determining Compensation Actually Paid for each year shown. The equity component of Compensation Actually Paid for each fiscal year is further detailed in the tables below:
Average NEO’s (other than Mr. Cordani) Compensation Actually Paid Equity Valuation for Each Fiscal Year
2023 Compensation Actually Paid Equity Valuation

Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2023
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2023
($)
Change in
Fair Value of
Awards that
Vested in 2023
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2023
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$1,100,520$(639,461)$(594,895)$0$(133,836)
Restricted
Stock		$1,152,358$(138,275)$(182,536)$0$831,548
Strategic Perf Shares$2,071,979$(1,252,141)$(297,218)$0$522,621
Total$4,324,857$(2,029,877)$(1,074,648)$0$1,220,332
2022 Compensation Actually Paid Equity Valuation
Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2022
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2022
($)
Change in
Fair Value of
Awards that
Vested in 2022
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2022
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$2,714,064$1,556,183$91,685$0$4,361,932
Restricted Stock
$1,458,559$444,168$36,761$0$1,939,488
Strategic Perf Shares$4,077,759$3,008,083$33$0$7,436,426
Total$8,250,382$5,008,434$128,479$0$13,387,296
2021 Compensation Actually Paid Equity Valuation
Award Type
Fair Value
of Awards
Granted in
Current Year
Outstanding
and Unvested
as of 12/31/2021
($)
Change in
Fair Value of
Outstanding
and Unvested
Prior Year
Awards as of
12/31/2021
($)
Change in
Fair Value of
Awards that
Vested in 2021
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2021
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$1,349,900$84,814$(143,363)$0$1,291,351
Restricted
Stock
$1,198,577$132,175$(345,777)$0$984,975
Strategic Perf Shares$1,861,457$(1,240,350)$49,621$147,252$523,476
Total$4,409,934$(1,023,361)$(439,519)$147,252$2,799,802

 
2020 Compensation Actually Paid Equity Valuation
Award Type
Fair Value of Awards Granted in
Current Year
Outstanding and Unvested as of 12/31/2020
($)
Change in Fair Value of Outstanding and Unvested Prior Year Awards as of
12/31/2020
($)
Change in
Fair Value of
Awards that
Vested in 2020
($)
Fair Value
of Awards
Forfeited or
Cancelled in
2020
($)
Equity Value in
Compensation
Actually Paid
($)
(a)(b)(c)(d)(e) = (a) + (b) + (c) - (d)
Stock Options$1,159,710$(52,264)$(444,007)$0$663,439
Restricted
Stock
$1,173,719$35,275$(56,462)$0$1,152,532
Strategic Perf Shares$2,452,495$(533,442)$(352,015)$0$1,567,038
Total$4,785,924$(550,431)$(852,484)$0$3,383,009
(3)No pension-related adjustments associated with the Cigna Pension Plan were necessary in the calculation of Compensation Actually Paid as the plan is frozen and there were no prior service costs established in the last three years.
      
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid versus Company TSR and Peer Group TSR
From 2020 through 2023, Mr. Cordani and the other NEOs’ Compensation Actually Paid amounts were generally aligned with the Company’s absolute TSR and its relative TSR as compared to the peer group used for this Pay Versus Performance analysis, namely the S&P 500 Health Care Index. This is due primarily to the Company’s use of equity incentives, which are tied directly to the Company’s stock price and financial performance on an absolute basis and relative to its peers. In addition, 50% of an SPS award’s payout is aligned to relative TSR performance as compared to a custom peer group, which has changed over time and, for awards granted in 2020 and 2021, differs from the broader S&P 500 Health Care Index.
The Company’s TSR underperformed relative to the S&P 500 Health Care Index in 2020 and 2021, leading to annual Compensation Actually Paid values that were lower than their relative Summary Compensation Table values in those fiscal years. In 2022, however, the Company saw significant TSR growth and outperformed the peer group. This stock price growth translated to significantly increased Compensation Actually Paid values for Mr. Cordani and the other NEOs for 2022. The Company’s TSR for 2023 was lower than the Company’s 2022 TSR on an absolute and relative basis, leading to Compensation Actually Paid values that were lower than both the Summary Compensation Table value for 2023 and the 2022 Compensation Actually Paid values.
The graph below compares The Cigna Group cumulative TSR to the S&P 500 Index and the S&P 500 Health Care Index for the five-year period ended December 31, 2023, which we believe provides a more fulsome understanding of the Company’s market performance given the longer time horizon. The stock performance shown in the graph is not intended to forecast or be indicative of future performance.
7626  
*Assumes that the value of the investment in Cigna common stock and each index was $100 on December 31, 2018 and that all dividends were reinvested.
      
Compensation Actually Paid vs. Net Income
Compensation Actually Paid versus Net Income
The Company’s annual net income in 2023 was slightly below 2022, primarily driven by the recognition of a loss on the sale of a business. Between 2020 and 2022, Mr. Cordani and other NEOs’ Compensation Actually Paid has generally appreciated, but decreased in 2023. This is due to the following:
•the significant emphasis the Company places on equity incentives, which are more sensitive to absolute stock price performance and stock price performance relative to peers; and
•the fact that the Company does not use year-over-year changes in net income to determine compensation levels or incentive plan payouts. Instead, adjusted income from operations has been the Company’s income measure of performance in its incentive plans and one of the Company’s most important performance measures for determining compensation. 		     
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid versus Adjusted Income from Operations per Share
Similar to the discussion of the relationship between Compensation Actually Paid and Company/Peer Group TSR above, Mr. Cordani and other NEOs’ Compensation Actually Paid amounts are generally aligned with the Company’s adjusted income from operations per share results over the reporting period. Adjusted income from operations per share long-term goals account for 50% of each SPS award’s total payout. Final results for adjusted income from operations per shares in years 2021, 2022, and 2023, relative to internal goals established at the beginning of each SPS award’s performance measurement period, have contributed to the Compensation Actually Paid values for Mr. Cordani and other NEOs seen in 2023. By the end of 2023, all SPS awards granted in years 2021, 2022, and 2023 were trending above their targeted adjusted income from operations per share results. 		     
Total Shareholder Return Vs Peer Group
Compensation Actually Paid versus Company TSR and Peer Group TSR
From 2020 through 2023, Mr. Cordani and the other NEOs’ Compensation Actually Paid amounts were generally aligned with the Company’s absolute TSR and its relative TSR as compared to the peer group used for this Pay Versus Performance analysis, namely the S&P 500 Health Care Index. This is due primarily to the Company’s use of equity incentives, which are tied directly to the Company’s stock price and financial performance on an absolute basis and relative to its peers. In addition, 50% of an SPS award’s payout is aligned to relative TSR performance as compared to a custom peer group, which has changed over time and, for awards granted in 2020 and 2021, differs from the broader S&P 500 Health Care Index.
The Company’s TSR underperformed relative to the S&P 500 Health Care Index in 2020 and 2021, leading to annual Compensation Actually Paid values that were lower than their relative Summary Compensation Table values in those fiscal years. In 2022, however, the Company saw significant TSR growth and outperformed the peer group. This stock price growth translated to significantly increased Compensation Actually Paid values for Mr. Cordani and the other NEOs for 2022. The Company’s TSR for 2023 was lower than the Company’s 2022 TSR on an absolute and relative basis, leading to Compensation Actually Paid values that were lower than both the Summary Compensation Table value for 2023 and the 2022 Compensation Actually Paid values.
The graph below compares The Cigna Group cumulative TSR to the S&P 500 Index and the S&P 500 Health Care Index for the five-year period ended December 31, 2023, which we believe provides a more fulsome understanding of the Company’s market performance given the longer time horizon. The stock performance shown in the graph is not intended to forecast or be indicative of future performance.
7626  
*Assumes that the value of the investment in Cigna common stock and each index was $100 on December 31, 2018 and that all dividends were reinvested.
      
Tabular List, Table
Most Important Company Performance Measures
Adjusted Income from OperationsAffordability and Effectiveness
Adjusted Revenues
Advancing ESG Initiatives
Relative Total Shareholder ReturnCross-Enterprise Leverage
Adjusted Income from Operations per Share

      
Total Shareholder Return Amount $ 154.34 167.71 114.34 101.83
Peer Group Total Shareholder Return Amount 143.18 140.29 143.09 113.45
Net Income (Loss) $ 5,164,000,000 $ 6,704,000,000 $ 5,370,000,000 $ 8,458,000,000
Company Selected Measure Amount | uS_Dollar_Per_Share 25.09 23.36 20.48 18.45
PEO Name Mr. Cordani      
Additional 402(v) Disclosure Reflects “Shareholders’ Net Income” per SEC requirements.Effective January 1, 2023, The Cigna Group adopted amended accounting guidance for long-duration insurance contracts. Fiscal year 2022 and 2021 amounts have been retrospectively adjusted to conform to this new basis of accounting. See Note 2 - Summary of Significant Accounting Policies to The Cigna Group’s consolidated financial statements in the Annual Report on Form 10-K for the year ended December 31, 2023 for additional information.
Most Important Measures in Determining FY2023 Compensation Actually Paid
The performance measures listed below represent the most important measures The Cigna Group used to determine Named Executive Officer compensation for fiscal year 2023. The use of each measure is further described in the Compensation Discussion and Analysis (CD&A) within the section titled “Elements of Compensation.” 		     
PEO Ratio Of Compensation Paid To Summary Compensation 39.00% 274.00% 78.00% 80.00%
Non-PEO NEO Ratio Of Compensation Paid To Summary Compensation 52.00% 244.00% 73.00% 84.00%
PEO Salary $ 1,500,000 $ 1,500,000 $ 1,500,000 $ 1,500,000
PEO Stock Awards 15,856,233 15,544,307 15,370,427 14,560,254
PEO Bonus And Non-Equity Incentive Compensation 3,300,000 3,600,000 2,700,000 3,500,000
PEO Other Compensation 310,437 321,197 301,839 179,341
PEO Change In Pension Value And Nonqualified Deferred Compensation Earnings 80,585 0 0 189,898
Non-PEO NEO Salary 875,288 827,549 995,385 1,001,923
Non-PEO NEO Stock Awards 4,500,529 4,236,986 4,731,519 4,503,476
Non-PEO NEO Bonus And Non-Equity Incentive Compensation 1,365,000 1,230,625 604,500 1,470,625
Non-PEO NEO Other Compensation 50,046 51,392 829,680 55,835
Non-PEO NEO Change In Pension Value And Nonqualified Deferred Compensation Earnings $ 10,466 0 3,131 43,903
Measure:: 1        
Pay vs Performance Disclosure        
Name Adjusted Income from Operations      
Measure:: 2        
Pay vs Performance Disclosure        
Name Adjusted Revenues      
Measure:: 3        
Pay vs Performance Disclosure        
Name Relative Total Shareholder Return      
Measure:: 4        
Pay vs Performance Disclosure        
Name Adjusted Income from Operations per Share      
Non-GAAP Measure Description For purposes of this section, we have identified Adjusted Income from Operations, per share as our Company-Selected Measure, the calculation of which is described in our Annual Report on Form 10-K for the year ended December 31, 2023. Additional information regarding our use of non-GAAP measures and reconciliations to the most directly comparable GAAP measure can be found on Annex A.      
Measure:: 5        
Pay vs Performance Disclosure        
Name Affordability and Effectiveness      
Measure:: 6        
Pay vs Performance Disclosure        
Name Advancing ESG Initiatives      
Measure:: 7        
Pay vs Performance Disclosure        
Name Cross-Enterprise Leverage      
PEO | Deductions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (15,856,233) (15,544,307) (15,370,427) (14,560,254)
PEO | Additions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,962,236 51,967,797 10,947,067 10,503,298
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 3,106,749 7,876,809 4,385,246 3,749,535
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (2,098,800) 6,875,723 382,720 (241,674)
PEO | Change In Fair Value Of Awards, Vested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (2,374,503) 444,986 (555,181) (1,637,861)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
PEO | Equity Award Adjustments, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (1,366,555) 15,197,518 4,212,785 1,870,000
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 3,252,626 4,232,869 3,893,606 3,794,705
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (451,849) 1,767,720 392,213 45,261
PEO | Change In Fair Value Of Awards, Vested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (640,466) 38,838 26,005 (114,871)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
PEO | Equity Award Adjustments, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 2,160,310 6,039,426 4,311,824 3,725,095
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 8,773,351 17,751,119 6,977,016 7,929,201
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (5,212,929) 12,979,546 (4,619,317) (1,965,506)
PEO | Change In Fair Value Of Awards, Vested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (1,391,941) 188 64,758 (1,055,492)
PEO | Fair Value Of Awards, Forfeited Or Cancelled, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
PEO | Equity Award Adjustments, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 2,168,481 30,730,853 2,422,457 4,908,203
PEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 15,132,725 29,860,797 15,255,868 15,473,441
PEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (7,763,578) 21,622,989 (3,844,384) (2,161,919)
PEO | Change In Fair Value Of Awards, Vested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (4,406,911) 484,012 (464,418) (2,808,224)
PEO | Fair Value Of Awards, Forfeited Or Cancelled [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
Non-PEO NEO | Deductions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (4,500,529) (4,236,986) (4,731,519) (4,503,476)
Non-PEO NEO | Additions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,220,332 13,387,296 2,799,802 3,383,009
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 1,100,520 2,714,064 1,349,900 1,159,710
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (639,461) 1,556,183 84,814 (52,264)
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (594,895) 91,685 (143,363) (444,007)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
Non-PEO NEO | Equity Award Adjustments, Stock Options [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (133,836) 4,361,932 1,291,351 663,439
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 1,152,358 1,458,559 1,198,577 1,173,719
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (138,275) 444,168 132,175 35,275
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (182,536) 36,761 (345,777) (56,462)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 0 0
Non-PEO NEO | Equity Award Adjustments, Restricted Stock [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 831,548 1,939,488 984,975 1,152,532
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 2,071,979 4,077,759 1,861,457 2,452,495
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (1,252,141) 3,008,083 (1,240,350) (533,442)
Non-PEO NEO | Change In Fair Value Of Awards, Vested, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (297,218) 33 49,621 (352,015)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 0 0 147,252 0
Non-PEO NEO | Equity Award Adjustments, Strategic Perf Shares [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 522,621 7,436,426 523,476 1,567,038
Non-PEO NEO | Fair Value Of Awards Granted In Current Year, Outstanding And Unvested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards 4,324,857 8,250,382 4,409,934 4,785,924
Non-PEO NEO | Change In Fair Value Of Awards From Prior Years, Outstanding And Unvested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (2,029,877) 5,008,434 (1,023,361) (550,431)
Non-PEO NEO | Change In Fair Value Of Awards, Vested [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards (1,074,648) 128,479 (439,519) (852,484)
Non-PEO NEO | Fair Value Of Awards, Forfeited Or Cancelled [Member]        
Pay vs Performance Disclosure        
Adjustment To Compensation Amount, Equity Awards $ 0 $ 0 $ 147,252 $ 0